Skip to main content
Produced by W2D1 Media. Work with us →
All companies

Emyria

Formerly Emerald Clinics (until September 2020)

1 conversation across 1 show.
Meet the people behind the company.

About Emyria

Emyria (ASX:EMD) is a Perth-based, ASX-listed biotech developing treatments for mental health and neurological conditions, including psychedelic-assisted therapies for PTSD and treatment-resistant depression. It runs its own clinical service subsidiaries to gather real-world patient data alongside its drug development programmes.

Sector
Clinical-stage biotech (mental health, neurological)
Founded
2018
Headquarters
Subiaco, Perth
Status
ASX-listed (ASX: EMD)

Sources: businessnewsaustralia.com, stockanalysis.com

The people on Day One.

Hear from the team.

Spot something wrong? Suggest a correctionUpdated 29 October 2026

Be part of
the conversation.

Put your brand alongside the voices founders, investors and operators come to hear.

Explore sponsorship

Want a show like this for your fund or company?

We're W2D1 Media — the team behind the Day One Network, and we helped build Blackbird Ventures' Wild Hearts. We turn podcasts into trust, authority and pipeline.

Book a call →